Pharmacological examination of trifluoromethyl ring-substituted methcathinone analogs

European Journal of Pharmacology

Volumn 699, Issue 1-3, 2013, Pages 180-187

  Cozzi, Nicholas V ^a,c   Brandt, Simon D ^b   Daley, Paul F ^c   Partilla, John S ^d   Rothman, Richard B ^d   Tulzer, Andreas ^e   Sitte, Harald H ^e   Baumann, Michael H ^d  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^c Alexander Shulgin Research Institute   (United States)

^d NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Bath salts; Cathinone; Designer drug; Dopamine; Mephedrone; Methylone; Monoamine transporter; Norepinephrine; Serotonin

Indexed keywords

2 TRIFLUOROMETHYLMETHCATHINONE; 3 TRIFLUOROMETHYLMETHCATHINONE; 4 TRIFLUOROMETHYLMETHCATHINONE; CENTRAL STIMULANT AGENT; DOPAMINE; DOPAMINE TRANSPORTER; METHCATHINONE; METHCATHINONE DERIVATIVE; NORADRENALIN TRANSPORTER; SEROTONIN; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; EMBRYO; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; ISOMER; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; THROMBOCYTE;

ANIMALS; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; MALE; MOTOR ACTIVITY; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; NUCLEUS ACCUMBENS; PROPIOPHENONES; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 84871945439     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.11.008     Document Type: Article

References (41)

1. G.A. Alles, M.D. Fairchild, and M. Jensen Chemical pharmacology of Catha edulis J. Med. Pharm. Chem. 3 1961 323 352
2. Anonymous Schedules of controlled substances: temporary placement of three synthetic cathinones into schedule I Fed. Regist. 76 2011 65371 65375
3. M.H. Baumann, M.A. Ayestas, J.S. Partilla, J.R. Sink, A.T. Shulgin, P.F. Daley, S.D. Brandt, R.B. Rothman, A.E. Ruoho, and N.V. Cozzi The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue Neuropsychopharmacology 37 2012 1192 1203
4. M.H. Baumann, R.D. Clark, and R.B. Rothman Locomotor stimulation produced by 3,4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain Pharmacol. Biochem. Behav. 90 2008 208 217
5. M.H. Baumann, R.D. Clark, W.L. Woolverton, S. Wee, B.E. Blough, and R.B. Rothman In vivo effects of amphetamine analogs reveal evidence for serotonergic inhibition of mesolimbic dopamine transmission in the rat J. Pharmacol. Exp. Ther. 337 2011 218 225
6. R.D. Blakely, S. Ramamoorthy, Y. Qian, S. Schroeter, and C. Bradley Regulation of antidepressant-sensitive serotonin transporters M.E. Reith, Neurotransmitter Transporters: Structure, Function, and Regulation 1997 Humana Press Totowa, NJ 29 72
7. S.D. Brandt, P.F. Daley, and N.V. Cozzi Analytical characterization of three trifluoromethyl-substituted methcathinone isomers Drug Test. Anal. 4 2012 525 529
8. S.D. Brandt, S. Freeman, H.R. Sumnall, F. Measham, and J. Cole Analysis of NRG 'legal highs' in the UK: identification and formation of novel cathinones Drug Test. Anal. 3 2011 569 575
9. S.D. Brandt, H.R. Sumnall, F. Measham, and J. Cole Analyses of second-generation 'legal highs' in the UK: initial findings Drug Test. Anal. 2 2010 377 382
10. S. Bulling, K. Schicker, Y.W. Zhang, T. Steinkellner, T. Stockner, C.W. Gruber, S. Boehm, M. Freissmuth, G. Rudnick, H.H. Sitte, and W. Sandtner The mechanistic basis for noncompetitive ibogaine inhibition of serotonin and dopamine transporters J. Biol. Chem. 287 2012 18524 18534
11. F.I. Carroll, B.E. Blough, P. Abraham, A.C. Mills, J.A. Holleman, S.A. Wolckenhauer, A.M. Decker, A. Landavazo, K.T. McElroy, H.A. Navarro, M.B. Gatch, and M.J. Forster Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction J. Med. Chem. 52 2009 6768 6781
12. F.I. Carroll, B.E. Blough, S.W. Mascarella, H.A. Navarro, J.B. Eaton, R.J. Lukas, and M.I. Damaj Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation J. Med. Chem. 53 2010 2204-2014
13. N.V. Cozzi, and K.F. Foley Methcathinone is a substrate for the serotonin uptake transporter Pharmacol. Toxicol. 93 2003 219 225
14. N.V. Cozzi, K.F. Foley, D. Fontanilla, A. Gopalakrishnan, and A.E. Ruoho A novel amphetamine-related photoaffinity probe FASEB J. 21 2007 715.2
15. N.V. Cozzi, D. Marona-Lewicka, D.E. Nichols, A. Gokin, and K.F. Foley Novel aminopropiophenones as antiobesity agents Soc. Neurosci. Abs. 31 2005 533.5
16. N.V. Cozzi, M.K. Sievert, A.T. Shulgin, P. Jacob III, and A.E. Ruoho Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines Eur. J. Pharmacol. 381 1999 63 69
17. T.A. Dal Cason, R. Young, and R.A. Glennon Cathinone: an investigation of several N-alkyl and methylenedioxy-substituted analogs Pharmacol. Biochem. Behav. 58 1997 1109 1116
18. EMCDDA, 2011. Report on the Risk Assessment of Mephedrone in the Framework of the Council Decision on New Psychoactive Substances. Publications Office of the European Union, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 200 pp.
19. EMCDDA, 2012. EMCDDA-Europol 2011 Annual Report on the Implementation of Council Decision 2005/387/JHA. European Monitoring Centre for Drugs and Drug Addiction & EUROPOL, Lisbon, 29 pp.
20. Foley, K.F., 2002. Aminopropiophenones at the Norepinephrine Transporter: Structure-activity Relationships and Behavioral Effects of Methcathinone Analogs. Ph.D. Thesis, East Carolina University, Greenville, NC, 130 pp.
21. K.F. Foley, and N.V. Cozzi Novel aminopropiophenones as potential antidepressants Drug Dev. Res. 60 2003 252 260
22. M. Fujioka, and H. Kuriyama Eperisone, an antispastic agent, possesses vasodilating actions on the guinea-pig basilar artery J. Pharmacol. Exp. Ther. 235 1985 757 763
23. R.A. Glennon, M. Yousif, N. Naiman, and P. Kalix Methcathinone: a new and potent amphetamine-like agent Pharmacol. Biochem. Behav. 26 1987 547 551
24. T. Hiyama Organofluorine Compounds: Chemistry and Applications 2000 Springer-Verlag Berlin 284 pp.
25. D. Hofer, B. Lohberger, B. Steinecker, K. Schmidt, S. Quasthoff, and W. Schreibmayer A comparative study of the action of tolperisone on seven different voltage dependent sodium channel isoforms Eur. J. Pharmacol. 538 2006 5 14
26. J. Kehr, F. Ichinose, S. Yoshitake, M. Goiny, T. Sievertsson, F. Nyberg, and T. Yoshitake Mephedrone, compared to MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and serotonin levels in nucleus accumbens of awake rats Br. J. Pharmacol. 164 2011 1949 1958
27. J.P. Kelly Cathinone derivatives: a review of their chemistry, pharmacology and toxicology Drug Test. Anal. 3 2011 439 453
28. P. Kocsis, S. Farkas, L. Fodor, N. Bielik, M. Than, S. Kolok, A. Gere, M. Csejtei, and I. Tarnawa Tolperisone-type drugs inhibit spinal reflexes via blockade of voltage-gated sodium and calcium channels J. Pharmacol. Exp. Ther. 315 2005 1237 1246
29. R.J. Lukas, A.Z. Muresan, M.I. Damaj, B.E. Blough, X. Huang, H.A. Navarro, S.W. Mascarella, J.B. Eaton, S.K. Marxer-Miller, and F.I. Carroll Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation J. Med. Chem. 53 2010 4731 4748
30. M.C. Mithoefer, M.T. Wagner, A.T. Mithoefer, L. Jerome, and R. Doblin The safety and efficacy of (+/-) 3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study J. Psychopharmacol. 25 2011 439 452
31. D.E. Nichols, A.J. Hoffman, R.A. Oberlender, P., III Jacob, and A.T. Shulgin Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class J. Med. Chem. 29 1986 2009 2015
32. K. Nisijima, M. Shimizu, and T. Ishiguro Treatment of tardive dystonia with an antispastic agent Acta Psychiatry Scand. 98 1998 341 343
33. M.C. Ritz, E.J. Cone, and M.J. Kuhar Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study Life Sci. 46 1990 635 645
34. R.B. Rothman, and M.H. Baumann Monoamine transporters and psychostimulant drugs Eur. J. Pharmacol. 479 2003 23 40
35. R.B. Rothman, N. Vu, J.S. Partilla, B.L. Roth, S.J. Hufeisen, B.A. Compton-Toth, J. Birkes, R. Young, and R.A. Glennon In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates J. Pharmacol. Exp. Ther. 307 2003 138 145
36. E. Schmidt, and A. Eberhard Ueber das ephedrin und verwandte verbindungen Arch. Pharm. (Weinheim). 253 1915 62 91
37. A. Shiozawa, K. Narita, G. Izumi, S. Kurashige, K. Sakitama, and M. Ishikawa Synthesis and activity of 2-methyl-3-aminopropiophenones as centrally acting muscle relaxants Eur. J. Med. Chem. 30 1995 85 94
38. J.E. Slemmer, B.R. Martin, and M.I. Damaj Bupropion is a nicotinic antagonist J. Pharmacol. Exp. Ther. 295 2000 321 327
39. I. Vardakou, C. Pistos, and C. Spiliopoulou Drugs for youth via Internet and the example of mephedrone Toxicol. Lett. 201 2011 191 195
40. S.C. Wall, H. Gu, and G. Rudnick Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux Mol. Pharmacol. 47 1995 544 550
41. K.Y. Zhingel, W. Dovensky, A. Crossman, and A. Allen Ephedrone: 2-methylamino-1-phenylpropan-1-one (Jeff) J. Forensic Sci. 36 1991 915 920